Arena Pharmaceuticals (Nasdaq: ARNA) is lower on active volume Monday heading into the company's Q1 report, which is expected out ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE